Respiratorius AB (publ) (XSAT: RESP)
Health Care · Biotechnology · SE
Skr—
— today · — 1Y
Respiratorius AB (publ) (XSAT: RESP) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.72M.
trading between 1.19 and 3.54.
Tweenvest scores Respiratorius AB (publ) across four factors: quality 54/100, value 27/100. Its strongest factor is quality.
RESP price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.72M
- Revenue (TTM)
- $3.10K
- P/E
- —
- EPS
- -0.91
- Dividend yield
- —
- Beta (5Y)
- 1.67
- 52-week high
- Skr3.54
- 52-week low
- Skr1.19
- Avg volume (3M)
- —
- Shares outstanding
- 7.90M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Onconetix, Inc.NasdaqCM: ONCO | $1.89M | $0.48 | -22.77% |
| Silo Pharma, Inc.NasdaqCM: SILO | $1.87M | $1.18 | -19.73% |
| Cynata Therapeutics LimitedASX: CYP | $1.86M | AU$0.01 | -21.43% |
| Neural Therapeutics Inc.CNSX: NURL | $1.79M | CA$0.02 | -25.00% |
| Curis, Inc.NasdaqCM: CRIS | $1.59M | $0.39 | -4.59% |
| Genprex, Inc.NasdaqCM: GNPX | $1.48M | $1.81 | -8.59% |
| BioSenic S.A.ENXTBR: BIOS | $1.47M | €0.00 | -9.09% |
| Hexima LimitedASX: HXL | $1.44M | AU$— | — |
Figures last refreshed Oct 18, 2026.